With so many variables impacting the commercialization process, we pulled together some examples of how firms successfully bring new products to market. There are plenty of difficult tasks when ...
The previous chapter provided descriptive evidence around the landscape of SBIR/STTR winners. This report now turns to the observable impact of the DOE SBIR/STTR programs on key dimensions of ...
This article explores the steps taken to commercializing flexible hybrid electronics, including an example of an FHE solution that has already come on to the market. The starting point for roadmaps ...
In an interview with Pharm Exec Associate Editor Don Tracy, Melissa Lattanzi, VP, Emerging Therapies, Cencora discusses ways that cell and gene therapy developers can follow examples from the ...